Brief: Cormedix Inc Announces Resubmission Of New Drug Application For Defencath
16/05/2023 12:02
May 16 (Reuters) - CorMedix Inc CRMD.O :
* CORMEDIX INC. ANNOUNCES RESUBMISSION OF NEW DRUG
APPLICATION FOR
DEFENCATH
Source text for Eikon: ID:nGNX7kLy2P
Further company coverage: CRMD.O
Recent news on CorMedix
See all newsBrief: Cormedix Announces FDA Acceptance For Priority Review Of Supplemental NDA For Rezzayo
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce
U.S. STOCKS ON THE MOVE-Cerebras, Madison Square Garden Sports
CorMedix Inc. reports results for the quarter ended June 30 - Earnings Summary